Neurovascular Devices Market - By Product (Embolic Coils, Carotid Stents, Intracranial Stents, Catheters, Embolic Protection Devices, Flow Diverters, Stent Retrievers, Guidewires), By Process, Therapeutic Applications, End-use & Global Forecast, 2023-2032

Notable firms in the neurovascular devices industry include Asahi Intecc Co. Ltd., Integer Holdings Corporation, Johnson & Johnson Services, Kaneka Medix Corp. Medtronic, MicroPort Scientific Corporation, Merit Medical System, Penumbra, Inc., Stryker, and Terumo Corporation.

The ischemic stroke segment amassed over 40% of the global market share in 2022, given the growing prevalence of ischemic strokes and the rising popularity of minimally invasive procedures.

The neurovascular devices market from the flow diverters segment is estimated to witness a 7.5% CAGR through 2032, attributed to an increased cognizance of distinctive treatment options for intracranial aneurysm.

Global market for neurovascular devices was valued at USD 3.9 billion in 2022 and is poised to exhibit a 6.5% CAGR from 2023 to 2032 due to the surging prevalence of ischemic strokes and brain aneurysm across North America.